Odyssey Therapeutics, Inc. (ODTX) - Form 8-K Summary
Business Context and Reporting Period
Odyssey Therapeutics, Inc., a Delaware corporation, filed this Current Report on Form 8-K on June 23, 2026. The Company is an emerging growth company with its principal executive offices in Boston, Massachusetts. The filing serves to disclose a corporate presentation posted on the Company's investor relations website.
Financial Metrics
This filing does not contain specific financial data. The document does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses solely on the dissemination of a corporate presentation rather than the reporting of financial results.
Material Changes
No material changes to financial position or operations are reported in this document. The filing is informational, intended to satisfy Regulation FD disclosure requirements regarding the release of a corporate presentation.
Guidance, Outlook, and Risks
The filing references a corporate presentation dated June 2026 (Exhibit 99.1) which likely contains management commentary, outlook, and strategic updates. However, the text of the 8-K itself does not summarize specific guidance, risks, contingencies, or unusual items. The Company explicitly states that the information in the presentation is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the content of the corporate presentation (Exhibit 99.1) at the provided investor relations URL for detailed strategic updates.
- Confirm that the presentation is not incorporated by reference into other filings unless explicitly stated.
- Note that this 8-K does not include audited or unaudited financial statements.
- Review the presentation for any forward-looking statements regarding clinical trials or product development, as these are not detailed in the 8-K text.